> Huntingdon Life Sciences, a U.K. CRO, is planning to cut 8% of its workforce, or about 100 jobs, to survive dwindling demand. News
> Indian regulators are considering forcing the closure of more than 50 pharma and CMO plants in Andhra Pradesh. Article
> S&P predicts that Quintiles can sustain its organic growth and snatch up even more market share in 2013. Story
> Avid Bioservices has completed all of its manufacturing upgrades, designed to help it commercialize Peregrine's bavituximab and Cotara. Item
> INC Research has notched its 500th QuickStart Camp enrollment, celebrating a program designed to help investigators plan accurate and efficacious studies. Release
> Presented with minimal comment: a Canadian Medical Association Journal analysis on how Mayan doomsday would (or will, if you're into that) affect outcomes in clinical trials. Study